During the past decade, Specialty Retina Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Specialty Retina Center" #1 collaborator was "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Specialty Retina Center" are "Dry Eye" (1 trials), "Macular Edema" (1 trials), "Neovascular Age-Related Macular Degeneration" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Specialty Retina Center" in a lesser frequency.

Most popular intervention types in "Specialty Retina Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Drug: GB-102" (1 trials), "HL036 Ophthalmic Solution" (1 trials), "Lucentis or Avastin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specialty Retina Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Specialty Retina Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Specialty Retina Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Specialty Retina Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".